![[PDF]](/pb-assets/Icons/adobe-pdf-icon-1498649896243.png){kind=icon}
Abstract
This study aimed to evaluate the effect of intermittent teriparatide treatment on changes in bone formation using unidirectional porous beta-tricalcium phosphate in a rabbit bone defect model. Twelve Japanese white rabbits were used in this study. A 5 × 8 mm2 rectangular area of periosteum was resected, followed by preparation of a cortical bone defect in a 4.5 × 7 mm2 rectangular area using a high-speed bur. Unidirectional porous beta-tricalcium phosphate was embedded in the defect in the direction of the pores, parallel to the axis of the tibia. Six rabbits in the teriparatide group were subcutaneously injected with 30 μg/kg of chemically synthesized teriparatide three times per week starting on the day of the operation, while six rabbits in the control group were injected with a hormone stock solution according to the same schedule. Tissue samples were harvested at six weeks after implantation. Newly formed bone was observed as a green area after using Villanueva–Goldner stain on sagittal sections. A region of interest with a height of 3 mm and width of 5 mm was set in the center of the artificial bone. A portion of the new bone in the region of interest was extracted using analysis software (BZ-X analyzer; Keyence, Japan), and the area ratio of the newly formed bone was calculated by dividing the area of the extracted portion by the area of the region of interest. As seen with sagittal Villanueva–Goldner staining, the percentage of new bone area in the region of interest was significantly larger in the teriparatide group (33 ± 9.0%) than in the control group (24 ± 3.9%). Unidirectional porous beta-tricalcium phosphate used alone sufficiently resulted in new bone formation, but as combined use of teriparatide further enhances new bone formation, promotion of bone fusion can be expected, leading to better clinical outcomes when applied to surgical procedures in real-world settings.
References
| 1. | Wang, W, Yeung, K. Bone grafts and biomaterials substitutes for bone defect repair: a review. Bioact Mater 2017; 2: 224–247. Google Scholar | Crossref | Medline |
| 2. | Azi, ML, Aprato, A, Joeris, A, et al. Autologous bone graft in the treatment of post-traumatic bone defects: a systematic review and meta-analysis. BMC Musculoskelet Disord 2016; 17: 465. Google Scholar | Crossref | Medline |
| 3. | Gamradt, SC, Lieberman, JR. Bone graft for revision hip arthroplasty: biology and future applications. Clin Orthop Relat Res 2003; 417: 183–194. Google Scholar |
| 4. | Rihn, JA, Kirkpatrick, K, Albert, TJ. Graft options in posterolateral and posterior interbody lumbar fusion. Spine (Phila Pa 1976) 2010; 35: 1629–1639. Google Scholar | Crossref | Medline | ISI |
| 5. | Ebraheim, NA, Elgafy, H, Xu, R. Bone-graft harvesting from iliac and fibular donor sites: techniques and complications. J Am Acad Orthop Surg 2001; 9: 210–218. Google Scholar | Crossref | Medline |
| 6. | Egol, KA, Nauth, A, Lee, M, et al. Bone grafting: sourcing, timing, strategies, and alternatives. J Orthop Trauma 2015; 29: S10–S14. Google Scholar | Crossref | Medline |
| 7. | Calori, GM, Mazza, E, Colombo, M, et al. The use of bone-graft substitutes in large bone defects: any specific needs? Injury 2011; 42: S56–S63. Google Scholar | Crossref | Medline |
| 8. | Ginebra, MP, Espanol, M, Maazouz, Y, et al. Bioceramics and bone healing. EFORT Open Rev 2018; 3: 173–183. Google Scholar | Crossref | Medline |
| 9. | Hing, KA, Wilson, LF, Buckland, T. Comparative performance of three ceramic bone graft substitutes. Spine J 2007; 7: 475–490. Google Scholar | Crossref | Medline | ISI |
| 10. | Chazono, M, Tanaka, T, Komaki, H, et al. Bone formation and bioresorption after implantation of injectable beta-tricalcium phosphate granules-hyaluronate complex in rabbit bone defects. J Biomed Mater Res A 2004; 70: 542–549. Google Scholar | Crossref | Medline | ISI |
| 11. | Makihara, T, Noguchi, H, Yamazaki, M, et al. The balance between bone formation and material resorption in unidirectional porous β-tricalcium phosphate implanted in a rabbit tibia. Key Eng Mater 2016; 696: 177–182. Google Scholar | Crossref |
| 12. | Kumagai, H, Abe, T, Koda, M, et al. Unidirectional porous beta-tricalcium phosphate induces bony fusion in lateral lumbar interbody fusion. J Clin Neurosci 2019; 59: 232–235. Google Scholar | Crossref | Medline |
| 13. | Kumagai, H, Iwasashi, M, Funayama, T, et al. Surgical repair of acetabular fracture using unidirectional porous beta-tricalcium phosphate. Case Rep Orthop 2019; 2019: 6860591. Google Scholar | Medline |
| 14. | Zhu, S, Song, D, Jiang, X, et al. Combined effects of recombinant human BMP-2 and Nell-1 on bone regeneration in rapid distraction osteogenesis of rabbit tibia. Injury 2011; 42: 1467–1473. Google Scholar | Crossref | Medline |
| 15. | Szponder, T, Wessely-Szponder, J, Sobczynska-Rak, A, et al. Application of platelet-rich plasma and tricalcium phosphate in the treatment of comminuted fractures in animals. In Vivo 2018; 32: 1449–1455. Google Scholar | Crossref | Medline |
| 16. | Komaki, H, Tanaka, T, Chazono, M, et al. Repair of segmental bone defects in rabbit tibiae using a complex of β-tricalcium phosphate, type I collagen, and fibroblast growth factor-2. Biomaterials 2006; 27: 5118–5126. Google Scholar | Crossref | Medline |
| 17. | Wang, X, Mabrey, JD, Agrawal, CM. An interspecies comparison of bone fracture properties. Biomed Mater Eng 1998; 8: 1–9. Google Scholar | Medline | ISI |
| 18. | Takakura, A, Lee, JW, Iimura, T, et al. Administration frequency as well as dosage of PTH are associated with development of cortical porosity in ovariectomized rats. Bone Res 2017; 5: 17002. Google Scholar | Crossref | Medline |
| 19. | Nakajima, A, Shimoji, N, Yamazaki, M, et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1–34). J Bone Miner Res 2002; 17: 2038–2047. Google Scholar | Crossref | Medline | ISI |
| 20. | Diez-Perez, A, Marin, F, Delgado-Rodriguez, M, et al. Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: a systematic review and meta-analysis. Bone 2019; 120: 1–8. Google Scholar | Crossref | Medline |
| 21. | Kim, SM, Kang, KC, Hahn, MH, et al. Current role and application of teriparatide in fracture healing of osteoporotic patients: a systematic review. J Bone Metab 2017; 24: 65–73. Google Scholar | Crossref | Medline |
| 22. | Iwasashi, M, Funayama, T, Sakane, M, et al. Bone regeneration and remodeling within a unidirectional porous hydroxyapatite bone substitute at a cortical bone defect site: histological analysis at one and two years after implantation. Materials (Basel) 2015; 8: 4884–4894. Google Scholar | Crossref | Medline |
| 23. | Makihara, T, Sakane, M, Yamazaki, M, et al. Formation of osteon-like structures in unidirectional porous hydroxyapatite substitute. J Biomed Mater Res B Res 2018; 106: 2665–2672. Google Scholar | Crossref | Medline |
| 24. | Nakamura, T, Sugimoto, T, Shiraki, M, et al. Randomized teriparatide [human parathyroid hormone (PTH) 1–34] once-weekly efficacy research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk. J Clin Endocrinol Metab 2012; 97: 3097–3106. Google Scholar | Crossref | Medline | ISI |
| 25. | Canalis, E, Giustina, A, Bilezikian, JP. Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 2007; 357: 905–916. Google Scholar | Crossref | Medline | ISI |
| 26. | Ohtori, S, Inoue, G, Toyone, T, et al. Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study. Spine (Phila Pa 1976) 2012; 37: E1464–E1468. Google Scholar | Crossref | Medline | ISI |
| 27. | Ogose, A, Kondo, N, Endo, N, et al. Histological assessment in grafts of highly purified beta-tricalcium phosphate (OSferion) in human bones. Biomaterials 2006; 27: 1542–1549. Google Scholar | Crossref | Medline | ISI |
| 28. | Furuya, M, Kikuta, J, Ishii, M, et al. Direct cell-cell contact between mature osteoblasts and osteoclasts dynamically controls their functions in vivo. Nat Commun 2018; 9: 300. Google Scholar | Crossref | Medline |
| 29. | Izawa, S, Funayama, T, Yamazaki, M, et al. The use of unidirectional porous β-tricarcium phosphate in surgery for calcaneal fractures: a report of four cases. Foot Ankle Online J 2017; 10: 2–6. Google Scholar | Medline |
| 30. | Jilka, RL. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 2007; 40: 1434–1446. Google Scholar | Crossref | Medline | ISI |
| 31. | Komatsu, J, Nagura, N, Iwase, H, et al. Effect of intermittent administration of teriparatide on the mechanical and histological changes in bone grafted with β-tricalcium phosphate using a rabbit bone defect model. Exp Ther Med 2017; 15: 19–30. Google Scholar | Medline |
| 32. | Jacobson, JA, Yanoso-Scholl, L, Reynolds, DG, et al. Teriparatide therapy and beta-tricalcium phosphate enhance scaffold reconstruction of mouse femoral defects. Tissue Eng Part A 2011; 17: 389–398. Google Scholar | Crossref | Medline | ISI |
| 33. | Takao-Kawabata, R, Isogai, Y, Ishizuya, T, et al. Three-times-weekly administration of teriparatide improves vertebral and peripheral bone density, microarchitecture, and mechanical properties without accelerating bone resorption in ovariectomized rats. Calcif Tissue Int 2015; 97: 156–168. Google Scholar | Crossref | Medline |
